Cure My Disease

Don't miss your cure!

 Log in / Sign up

Tiny drips, big risk: new protocol aims to cut hidden fluids for newborns in intensive care

NCT ID NCT07715513

Disease control Sponsor: University Hospital, Clermont-Ferrand Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

Newborns in intensive care often receive multiple intravenous treatments, and the hidden fluid from these infusions can build up, raising the risk of complications. This study tests a new care protocol designed to reduce that hidden fluid intake. Researchers will compare fluid volumes before and after the protocol change in newborns weighing between 500g and 4500g.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a new care protocol to reduce hidden fluid intake from intravenous treatments
What this could lead to
If successful, this could lead to a standardized care protocol that reduces fluid overload complications in newborns in intensive care.
What could go wrong
This is a very small, early study with only 9 participants, so results may not apply broadly. The intervention is a procedural change, not a drug, so its impact may be limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

9 people

The number who actually took part.

Started

Jun 2024

Finished

Sep 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

premature admitted in neonatal intensive care

Ages

1 day and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * newborns in neonatal intensive care * gestational age between 24 to 37 weeks of amenorrhoea * weight birth between 500g to 4500g Exclusion Criteria: * newborn without intravenous divice

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Neonatal intensive care unit are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Premature Birth

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Neonatal intensive care unit

Contacts and locations

Locations

  • CHU Clermont-Ferrand

    Clermont-Ferrand, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.